Company registration number SC349757 (Scotland)
TROON HEALTHCARE LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
PAGES FOR FILING WITH REGISTRAR
TROON HEALTHCARE LTD
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 6
TROON HEALTHCARE LTD
BALANCE SHEET
AS AT
31 JANUARY 2026
31 January 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
4
125,022
202,038
Current assets
Stocks
7,000
7,100
Debtors
5
228,074
280,051
Cash at bank and in hand
207,909
122,988
442,983
410,139
Creditors: amounts falling due within one year
7
(217,620)
(251,502)
Net current assets
225,363
158,637
Total assets less current liabilities
350,385
360,675
Provisions for liabilities
(17,626)
(19,914)
Net assets
332,759
340,761
Capital and reserves
Called up share capital
100
103
Capital redemption reserve
3
-
0
Profit and loss reserves
332,656
340,658
Total equity
332,759
340,761

For the financial year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 17 June 2026
S Shafiq
Director
Company registration number SC349757 (Scotland)
TROON HEALTHCARE LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 JANUARY 2026
- 2 -
Share capital
Capital redemption reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 February 2024
103
-
0
322,080
322,183
Year ended 31 January 2025:
Profit and total comprehensive income
-
-
98,578
98,578
Dividends
-
-
(80,000)
(80,000)
Balance at 31 January 2025
103
-
0
340,658
340,761
Year ended 31 January 2026:
Profit and total comprehensive income
-
-
136,280
136,280
Dividends
-
-
(80,000)
(80,000)
Redemption of shares
(3)
3
-
0
-
0
Transfers
-
-
(64,282)
(64,282)
Balance at 31 January 2026
100
3
332,656
332,759

The notes on pages 3 to 6 form part of these financial statements.

TROON HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
- 3 -
1
Accounting policies
Company information

Troon Healthcare Ltd is a private company limited by shares incorporated in Scotland. The registered office is 6th, Floor Gordon Chambers, 90 Mitchell Street, Glasgow, United Kingdom, G1 3NQ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

1.2
Revenue

Turnover represents the amounts derived from the provision of services which fall within the company's ordinary activities. Revenue is recognised on despatch of services.

Revenue from the sale of goods is recognised at a point in time when control of the goods, including the significant risks and rewards of ownership, have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised over time by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.3
Intangible fixed assets - goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2009, has now been fully amortised.

1.4
Tangible fixed assets

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
2% on a straight line basis
Short leasehold
2% on a straight line basis
Plant and equipment
20% on a reducing balance basis
Fixtures and fittings
15% on a reducing balance basis
Computers
33% on a straight line basis
1.5
Stocks

Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

 

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

TROON HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 4 -
1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
16
18
TROON HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 5 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 February 2025
155,473
Disposals
(32,703)
At 31 January 2026
122,770
Amortisation and impairment
At 1 February 2025
155,473
Disposals
(32,703)
At 31 January 2026
122,770
Carrying amount
At 31 January 2026
-
0
At 31 January 2025
-
0
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 February 2025
153,295
361,209
514,504
Additions
-
0
24,462
24,462
Disposals
(80,000)
(147,273)
(227,273)
At 31 January 2026
73,295
238,398
311,693
Depreciation and impairment
At 1 February 2025
33,176
279,290
312,466
Depreciation charged in the year
1,466
6,114
7,580
Eliminated in respect of disposals
(15,184)
(118,191)
(133,375)
At 31 January 2026
19,458
167,213
186,671
Carrying amount
At 31 January 2026
53,837
71,185
125,022
At 31 January 2025
120,119
81,919
202,038
TROON HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 6 -
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
35,416
88,098
Other debtors
192,658
191,953
228,074
280,051
6
Demerger of assets

In November 2025, the company undertook a demerger whereby certain assets were transferred to a newly incorporated company, Carluke Healthcare Ltd under common shareholder control.

 

The transfer was accounted for at the carrying value of the assets and liabilities transferred.

 

The net book value of the assets transferred amounted to £64,282 and the principal assets transferred comprised of plant & equipment.

 

Following the demerger, the company has continued to operate its remaining business activities.

 

 

7
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
45,318
77,895
Taxation and social security
35,906
36,039
Other creditors
136,396
137,568
217,620
251,502
8
Related Party Disclosures

At 31 January 2026 the company was owed £192,283 by Companies under common directorship (2025: £191,953 ).

 

At 31 January 2026 the company owed £18 to Companies under common directorship (2025: £18).

2026-01-312025-02-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.301No description of principal activityS ShafiqSC3497572025-02-012026-01-31SC3497572026-01-31SC3497572025-01-31SC349757core:LandBuildings2026-01-31SC349757core:OtherPropertyPlantEquipment2026-01-31SC349757core:LandBuildings2025-01-31SC349757core:OtherPropertyPlantEquipment2025-01-31SC349757core:WithinOneYear2026-01-31SC349757core:WithinOneYear2025-01-31SC349757core:CurrentFinancialInstrumentscore:WithinOneYear2026-01-31SC349757core:CurrentFinancialInstrumentscore:WithinOneYear2025-01-31SC349757core:ShareCapital2026-01-31SC349757core:ShareCapital2025-01-31SC349757core:CapitalRedemptionReserve2026-01-31SC349757core:CapitalRedemptionReserve2025-01-31SC349757core:RetainedEarningsAccumulatedLosses2026-01-31SC349757core:RetainedEarningsAccumulatedLosses2025-01-31SC349757core:ShareCapital2024-01-31SC349757core:CapitalRedemptionReserve2024-01-31SC349757core:RetainedEarningsAccumulatedLosses2024-01-31SC349757bus:Director12025-02-012026-01-31SC349757core:RetainedEarningsAccumulatedLosses2024-02-012025-01-31SC3497572024-02-012025-01-31SC349757core:RetainedEarningsAccumulatedLosses2025-02-012026-01-31SC349757core:ShareCapital2025-02-012026-01-31SC349757core:Goodwill2025-02-012026-01-31SC349757core:LandBuildingscore:OwnedOrFreeholdAssets2025-02-012026-01-31SC349757core:LandBuildingscore:LongLeaseholdAssets2025-02-012026-01-31SC349757core:PlantMachinery2025-02-012026-01-31SC349757core:FurnitureFittings2025-02-012026-01-31SC349757core:ComputerEquipment2025-02-012026-01-31SC349757core:NetGoodwill2025-01-31SC349757core:NetGoodwill2026-01-31SC349757core:NetGoodwill2025-02-012026-01-31SC349757core:NetGoodwill2025-01-31SC349757core:LandBuildings2025-01-31SC349757core:OtherPropertyPlantEquipment2025-01-31SC3497572025-01-31SC349757core:LandBuildings2025-02-012026-01-31SC349757core:OtherPropertyPlantEquipment2025-02-012026-01-31SC349757core:CurrentFinancialInstruments2026-01-31SC349757core:CurrentFinancialInstruments2025-01-31SC349757bus:PrivateLimitedCompanyLtd2025-02-012026-01-31SC349757bus:SmallCompaniesRegimeForAccounts2025-02-012026-01-31SC349757bus:FRS1022025-02-012026-01-31SC349757bus:AuditExempt-NoAccountantsReport2025-02-012026-01-31SC349757bus:FullAccounts2025-02-012026-01-31xbrli:purexbrli:sharesiso4217:GBP